Clinical Trial Update: Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating proactive postvitrectomy use of conbercept to reduce postoperative complications in proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Proliferative Diabetic Retinopathy | Phase 2 | Status: UNKNOWN